Lupus (SLE): who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body

  NCT07649265· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  NCT07355218· EMD Serono Research & Development Institute, Inc.· Source

• A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

  NCT07332481· EMD Serono Research & Development Institute, Inc.· Source

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

  NCT05039619· Hoffmann-La Roche· Source

• A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· Janssen Research & Development, LLC· Source

• A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

  NCT06617325· UCB Biopharma SRL· Source

• A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

  NCT07363590· Merck Sharp & Dohme LLC· Source

• Safety of the Herpes Zoster Subunit Vaccine in Lupus

  NCT05559671· NYU Langone Health· Source

• Association of Inflammatory Biomarkers and Ferritin With Severity of Pediatric Systemic Lupus Erythematosus Patients

  NCT07901634· Desy Wulandari· Source

• A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus

  NCT07630714· AstraZeneca· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 33
• Mendelian Randomization Analysis 41
• CRISPR-Cas Systems 1
• Gene Expression Profiling 100
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 1
• Exome Sequencing 5
• Proteomics 35
• Metabolomics 22
• Mass Spectrometry 5
• Flow Cytometry 35
• Immunohistochemistry 8
• Liquid Biopsy 2
• Positron-Emission Tomography 4
• Magnetic Resonance Imaging 49
• Machine Learning 37
• Deep Learning 3
• Cohort Studies 111
• Genome-Wide Association Study 54

• A machine learning framework for the multi-class prediction of suicide attempt risk.

  Acta Psychol (Amst), Sept 2026

• Diagnostic Performance of Machine Learning for Systemic Lupus Erythematosus: Systematic Review and Meta-Analysis.

  J Med Internet Res, Sept 2026

• An explainable machine learning model for predicting in-hospital infection in patients with systemic lupus erythematosus.

  Ren Fail, Aug 2026

• [Prediction Model of Systemic Lupus Erythematosus Based on Machine Learning Algorithms].

  Zhongguo Shi Yan Xue Ye Xue Za Zhi, Aug 2026

• Machine learning models identify prognostic factors in systemic lupus erythematosus patients with epstein-barr virus infection.

  Clin Rheumatol, Jul 2026

• Network-based machine learning to identify biomarkers for systemic lupus erythematosus.

  BMC Biol, Jul 2026

• Development of a LASSO-based machine learning model for relapse prediction in lupus nephritis.

  Lupus Sci Med, Jun 2026

• Multi-cohort transcriptomic analysis with machine learning identifies interferon-related candidate genes in systemic lupus erythematosus.

  Autoimmunity, Jun 2026

• Multi-omics and machine learning uncover the MX1-ISG15-STAT1 synergistic axis as the core interferon signature in systemic lupus erythematosus and identify herbal-derived multi-target therapeutic candidates.

  Comput Biol Chem, May 2026

• SLA and DDX60L as potential diagnostic biomarkers for subclinical atherosclerosis in systemic lupus erythematosus: a transcriptomic and clinical validation study.

  Clin Rheumatol, May 2026

See which targets of this disease your abstract mentions, and go to the people working on them.